KRISTIN HORWOOD: Open Payments
NPI 1760736292 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,198 in 36 payments from 6 companies in 2025. Trend: 2023 $13,307 · 2024 $44,074 · 2025 $26,198
Speaker / faculty: $19,953Travel & lodging: $2,160Consulting: $1,725Food & beverage: $1,387Honoraria: $923Education: $50
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 17 | $12,377 |
| SOBI, INC | 15 | $11,468 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,275 |
| PharmaEssentia USA Corporation | 1 | $923 |
| ABBVIE INC. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $30 |
Products named: Jakafi, Vonjo, BESREMI, VENCLEXTA, OJJAARA.
Industry payments across CA — which companies pay providers there.
